The expression of the BCR::ABL oncogene, a hallmark of CML, is accompanied by reduced Bub1, Bub3, BubR1, and Mad2 expression resulting in mitotic checkpoint defects that lead to CIN in murine 32D cells15. This evidence concerns the gene BUB1 and chronic myelogenous leukemia, BCR-ABL1 positive.